WNK2 and rheumatoid arthritis: LINC02381 was described to target miR-133b in cervical cancer cells [23], and it could exacerbate rheumatoid arthritis by adsorbing miR-590-5p and activating the mitogen-activated protein kinase signaling pathway in fibroblast-like synoviocytes [22].